Home
Journal Information
About
Aims and Scope
Editorial Board
Editor in Chief
Open Access
Editorial Office
Editorial Policies
Journal Issues
Current Issue
In Press
All Issues
Contact Us
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
2008-5117
eISSN
:
2008-6830
Submit Your Paper
Instructions for Authors
Instructions for Reviewers
Editor in Chief
Editorial Board
Editorial Policies
English Editing Service
Indexing and Abstracting
Archive
Platinum Open Access
This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.
Indexing Info
Collaborator of
J Cardiovasc Thorac Res
. 2019;11(2): 79-84. doi:
10.15171/jcvtr.2019.15
PMID:
31384400
PMCID:
PMC6669424
Original Article
Evaluation of drugs used in chronic heart failure at tertiary care centre: a hospital based study
Rinku Ghimire
1
*
, Sahadeb Prasad Dhungana
2
Cited by CrossRef: 3
1- Alsultan M, Alamer R, Alammar F, Alzlaiq W, Alahmari A, Almalki Z, Alqarni F, Alshayban D, Alotaibi F, Asiri I, Alsultan F, Kurdi S, Almalki B. Prevalence of polypharmacy in heart failure patients: A retrospective cross-sectional study in a tertiary hospital in Saudi Arabia.
Saudi Pharmaceutical Journal
. 2023;31(12):101875
[Crossref]
2- Lee T, Cau A, Cheng M, Levin A, Lee T, Vinh D, Lamontagne F, Singer J, Walley K, Murthy S, Patrick D, Rewa O, Winston B, Marshall J, Boyd J, Tran K, Kalil A, Mcculoh R, Fowler R, Luther J, Russell J. Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors.
CJC Open
. 2021;3(7):965
[Crossref]
3- Tsutsui Y, Matsushima S, Enzan N, Noda E, Shinohara K, Hashimoto T, Ide T, Kinugawa S, Tsutsui H. Nationwide Temporal Trends in Clinical Characteristics and Treatment of Dilated Cardiomyopathy From 2003 to 2013 in Japan ― A Report From Clinical Personal Records ―.
Circ J
. 2023;87(4):500
[Crossref]
4- Nalado A, Saidu H. Prescription Patterns of Evidence-Based Heart Failure Medications in a Tertiary Hospital in North-Western Nigeria—A Retrospective Study. 2022;19(2):151
[Crossref]
5- Fuentes Artiles R, Meçani R, Muka T, Hunziker L, Capék L. Investigation of left ventricular ejection fraction in a Swiss heart failure population: Insights into mortality and sex differences.
ESC Heart Failure
. 2024;
[Crossref]
6- Russell J, Marshall J, Slutsky A, Murthy S, Sweet D, Lee T, Singer J, Patrick D, Du B, Peng Z, Cheng M, Burns K, Harhay M. Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection.
BMJ Open
. 2020;10(12):e040768
[Crossref]